HIGHLIGHTS
- who: Yangyang Wang from the Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide and one of the leading causes of cancer-related mortality with high tumor malignancy [1]Liver transplantation is a radical treatment for liver cancer, especially early-stage HCC [2]. The shortage of grafts and the risk of recurrence are the two main limitations of liver transplantation in clinical settings have published the Article: Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation, in the Journal: (JOURNAL) of December/25,/2021
- what: The authors aimed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.